These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1354342)

  • 41. The conformations of filamentous and soluble tau associated with Alzheimer paired helical filaments.
    Goux WJ
    Biochemistry; 2002 Nov; 41(46):13798-806. PubMed ID: 12427043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. One of the antigenic determinants of paired helical filaments is related to tau protein.
    Nukina N; Ihara Y
    J Biochem; 1986 May; 99(5):1541-4. PubMed ID: 2423512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
    Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
    Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do aluminium and/or glutamate induce Alz-50 reactivity? A light microscopic immunohistochemical study.
    Jones KR; Oorschot DE
    J Neurocytol; 1998 Jan; 27(1):45-57. PubMed ID: 9530999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons.
    Muñoz-Montaño JR; Moreno FJ; Avila J; Diaz-Nido J
    FEBS Lett; 1997 Jul; 411(2-3):183-8. PubMed ID: 9271202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.
    Hanger DP; Hughes K; Woodgett JR; Brion JP; Anderton BH
    Neurosci Lett; 1992 Nov; 147(1):58-62. PubMed ID: 1336152
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxidative stress induces dephosphorylation of tau in rat brain primary neuronal cultures.
    Davis DR; Anderton BH; Brion JP; Reynolds CH; Hanger DP
    J Neurochem; 1997 Apr; 68(4):1590-7. PubMed ID: 9084430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
    Ando K; Kabova A; Stygelbout V; Leroy K; Heraud C; Frédérick C; Suain V; Yilmaz Z; Authelet M; Dedecker R; Potier MC; Duyckaerts C; Brion JP
    J Alzheimers Dis; 2014; 40 Suppl 1():S135-45. PubMed ID: 24614899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of two distinct monoclonal antibodies to paired helical filaments: further evidence for fetal-type phosphorylation of the tau in paired helical filaments.
    Hasegawa M; Watanabe A; Takio K; Suzuki M; Arai T; Titani K; Ihara Y
    J Neurochem; 1993 Jun; 60(6):2068-77. PubMed ID: 7684067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
    Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
    Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Caspase-3-mediated cleavage of PHF-1 tau during apoptosis irrespective of excitotoxicity and oxidative stress: an implication to Alzheimer's disease.
    Kang HJ; Yoon WJ; Moon GJ; Kim DY; Sohn S; Kwon HJ; Gwag BJ
    Neurobiol Dis; 2005 Apr; 18(3):450-8. PubMed ID: 15755671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
    Papasozomenos SC
    Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
    Imahori K; Uchida T
    J Biochem; 1997 Feb; 121(2):179-88. PubMed ID: 9089387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoclonal antibody Alz-50 reacts with bovine and human serum albumin.
    Davis PK; Johnson GV
    J Neurosci Res; 1994 Dec; 39(5):589-94. PubMed ID: 7534357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
    Shin RW
    Gerontology; 1997; 43 Suppl 1():16-23. PubMed ID: 9187935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease.
    Jicha GA; Lane E; Vincent I; Otvos L; Hoffmann R; Davies P
    J Neurochem; 1997 Nov; 69(5):2087-95. PubMed ID: 9349554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased production of paired helical filament epitopes in a cell culture system reduces the turnover of tau.
    Vincent I; Rosado M; Kim E; Davies P
    J Neurochem; 1994 Feb; 62(2):715-23. PubMed ID: 7507514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tau isoform expression and phosphorylation state during differentiation of cultured neuronal cells.
    Smith CJ; Anderton BH; Davis DR; Gallo JM
    FEBS Lett; 1995 Nov; 375(3):243-8. PubMed ID: 7498509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tau epitopes are incorporated into a range of lesions in Alzheimer's disease.
    Joachim CL; Morris JH; Selkoe DJ; Kosik KS
    J Neuropathol Exp Neurol; 1987 Nov; 46(6):611-22. PubMed ID: 2443617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.